Live Cell Imaging Market By Product 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Live Cell Imaging Market
Live Cell Imaging Market: By Product (Instruments, Consumables & Software), By Technology (FRET, FISH, HCS, FRAP, RI, TRIF, MPE & Other), By Application (Cell Biology, Stem Cells, Developmental Biology & Drug Discovery) & By Region-Forecast (2016-2021)
Report Code : HCR 0174
Published: 25 February, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
Live cell imaging involves the study of living cells though the use of images acquired from imaging systems such as microscopes and high-content screening systems, to monitor cellular processes and internal structures in real time, and over time. It has become analytical tool for gaining critical insights into the fundamental nature of tissue and cellular function. Globally, increasing incidence of cancer, growing usage of high-content screening techniques in drug discovery, and government funding for cell-based research are the prime growth drivers of global live cell imaging market. In addition, application of live cell imaging techniques in personalized medicine and emerging economies such as China, India and others will create new opportunities for global live cell imaging market. However, higher cost, and lack of skilled professionals are the key restraints for global live cell imaging market.

This report identifies the global live cell imaging market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global live cell imaging market.
Live Cell Imaging Market

Geographically North America dominated global live cell imaging market, due to to increasing application of cell imaging techniques in cancer research. Asia Pacific is projected to have fastest growth, owing to rapidly growing government and corporate investment in the biotechnology sector, rising number of diagnostics laboratories in this region. Among all the applications, cell biology segment has the highest market share in global live cell imaging market.

This report segments global live cell imaging market on the basis of product, technology, application, and regional market as follows:
  • Live Cell Imaging Market, By Product: Instrument, Consumables, and Software
  • Live Cell Imaging Market, By Technology: Fluorescence Resonance Energy Transfer (FRET), Fluorescence in Situ Hybridization (FISH), High-Content Screening (HCS), Fluorescence Recovery After Photobleaching (FRAP), Ratiometric Imaging, Total Internal Reflection Fluorescence Microscopy (TRIF), Multiphoton Excitation Microscopy (MPE), and Other Technologies
  • Live Cell Imaging Market, By Application: Cell Biology, Stem Cells, Developmental Biology, and Drug Discovery
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the live cell imaging market. Some of the major companies’ profiles in detail are as follows:
  • Becton, Dickinson and Company
  • Carl Zeiss AG
  • Danaher Corporation (Leica Microsystems)
  • GE Healthcare (Subsidiary of General Electric Company)
  • Molecular Devices, LLC
1. Live Cell Imaging – Market Overview
2. Executive Summary
3. Live Cell Imaging Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Live Cell Imaging – Market Forces
   4.1. Drivers
      4.1.1. Increasing incidence of cancer
      4.1.2. Growing usage of high-content screening techniques in drug discovery
      4.1.3. Government funding for cell-based research
   4.2. Restraints
      4.2.1. Higher cost
      4.2.2. Lack of skilled professionals
   4.3. Opportunities
      4.3.1. Emerging economies
      4.3.2. Live cell imaging techniques being used in personalized medicine
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Live Cell Imaging Market, By Product
   5.1. Instruments
   5.2. Consumables
   5.3. Software
6. Live Cell Imaging Market, By Technology
   6.1. Fluorescence Resonance Energy Transfer (FRET)
   6.2. Fluorescence in Situ Hybridization (FISH)
   6.3. High-Content Screening (HCS)
   6.4. Fluorescence Recovery After Photobleaching (FRAP)
   6.5. Ratiometric Imaging
   6.6. Total Internal Reflection Fluorescence Microscopy (TRIF)
   6.7. Multiphoton Excitation Microscopy (MPE)
   6.8. Other Technologies
7. Live Cell Imaging Market, By Application
   7.1. Cell Biology
   7.2. Stem Cells
   7.3. Developmental Biology
   7.4. Drug Discovery
8. Global Live Cell Imaging Market, By Geography
   8.1. Europe
      8.1.1. Germany
      8.1.2. France
      8.1.3. Italy
      8.1.4. Spain
      8.1.5. Russia
      8.1.6. U.K.
      8.1.7. Rest of Europe
   8.2. Asia Pacific
      8.2.1. China
      8.2.2. India
      8.2.3. Japan
      8.2.4. South Korea
      8.2.5. Rest of Asia-Pacific
   8.3. North America
      8.3.1. U.S.
      8.3.2. Canada
      8.3.3. Mexico
   8.4. Rest of the World (RoW)
      8.4.1. Brazil
      8.4.2. Rest of RoW
9. Live Cell Imaging – Market Entropy
   9.1. Expansion
   9.2. Technological Developments
   9.3. Merger & Acquisitions, and Joint Ventures
   9.4. Supply- Contract
10. Company Profiles
   10.1. Becton, Dickinson and Company
      10.1.1. Introduction
      10.1.2. Financials
      10.1.3. Key Insights
      10.1.4. Key Strategy
      10.1.5. Product Portfolio
      10.1.6. SWOT Analysis
   10.2. Carl Zeiss AG
      10.2.1. Introduction
      10.2.2. Financials
      10.2.3. Key Insights
      10.2.4. Key Strategy
      10.2.5. Product Portfolio
      10.2.6. SWOT Analysis
   10.3. Danaher Corporation (Leica Microsystems)
      10.3.1. Introduction
      10.3.2. Financials
      10.3.3. Key Insights
      10.3.4. Key Strategy
      10.3.5. Product Portfolio
      10.3.6. SWOT Analysis
   10.4. GE Healthcare (Subsidiary of General Electric Company)
      10.4.1. Introduction
      10.4.2. Financials
      10.4.3. Key Insights
      10.4.4. Key Strategy
      10.4.5. Product Portfolio
      10.4.6. SWOT Analysis
   10.5. Molecular Devices, LLC
      10.5.1. Introduction
      10.5.2. Financials
      10.5.3. Key Insights
      10.5.4. Key Strategy
      10.5.5. Product Portfolio
      10.5.6. SWOT Analysis
   10.6. Nikon Corporation
      10.6.1. Introduction
      10.6.2. Financials
      10.6.3. Key Insights
      10.6.4. Key Strategy
      10.6.5. Product Portfolio
      10.6.6. SWOT Analysis
   10.7. Olympus Corporation
      10.7.1. Introduction
      10.7.2. Financials
      10.7.3. Key Insights
      10.7.4. Key Strategy
      10.7.5. Product Portfolio
      10.7.6. SWOT Analysis
   10.8. Perkinelmer, Inc.
      10.8.1. Introduction
      10.8.2. Financials
      10.8.3. Key Insights
      10.8.4. Key Strategy
      10.8.5. Product Portfolio
      10.8.6. SWOT Analysis
   10.9. Sigma-Aldrich Corporation
      10.9.1. Introduction
      10.9.2. Financials
      10.9.3. Key Insights
      10.9.4. Key Strategy
      10.9.5. Product Portfolio
      10.9.6. SWOT Analysis
   10.10. Thermo Fisher Scientific, Inc.
      10.10.1. Introduction
      10.10.2. Financials
      10.10.3. Key Insights
      10.10.4. Key Strategy
      10.10.5. Product Portfolio
      10.10.6. SWOT Analysis
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix

   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Expert Insights
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports